Approximately 43% of patients developed de novo diabetes following acute pancreatitis (AP). Among patients with de novo ...

Background: Pancreatic collections are a common complication of acute pancreatitis. In Latin America, information on the types of pancreatic collections and their management is limited and may vary ...

From the Thorndike Memorial Laboratory, Second and Fourth Medical Services (Harvard), Boston City Hospital and the Department of Medicine, Harvard Medical School. Myers — Assistant in Medicine, ...

Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. In this study, we engineered a TDN miRNA inhibitor designed ...

Delivered at the first meeting in the auditorium of the Joseph H. Pratt Diagnostic Hospital, December 6, 1938. Select the format you want to export the citation of this publication.

A new prediction model for infected pancreatic necrosis (IPN) in patients with acute pancreatitis (AP) offers a groundbreaking approach to improving patient outcomes. Developed by a team of ...

Pancreatic insufficiency is typically a secondary cause as the result of a particular disease such as: chronic pancreatitis, acute pancreatitis, cystic fibrosis (CF), and pancreatic cancer. It can ...

RABI-767 is an investigational small molecule lipase inhibitor that is administered by endoscopic ultrasound guided peripancreatic injection. The Food and Drug Administration (FDA) has granted Fast ...